1. Home
  2. Publications
  3. Characterizing genetic intra-tumor heterogeneity across 2,658...

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes

Abstract:
SUMMARY Intra-tumor heterogeneity (ITH) is a mechanism of therapeutic resistance and therefore an important clinical challenge. However, the extent, origin and drivers of ITH across cancer types are poorly understood. To address this question, we extensively characterize ITH across whole-genome sequences of 2,658 cancer samples, spanning 38 cancer types. Nearly all informative samples (95.1%) contain evidence of distinct subclonal expansions, with frequent branching relationships between subclones. We observe positive selection of subclonal driver mutations across most cancer types, and identify cancer type specific subclonal patterns of driver gene mutations, fusions, structural variants and copy-number alterations, as well as dynamic changes in mutational processes between subclonal expansions. Our results underline the importance of ITH and its drivers in tumor evolution, and provide an unprecedented pan-cancer resource of comprehensively annotated subclonal events from whole-genome sequencing data.
Authors:
S Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, A Deshwar, K Yu, Y Rubanova, G Macintyre, J Demeulemeester, I Vázquez-García, K Kleinheinz, D Livitz, S Malikic, N Donmez, S Sengupta, P Anur, C Jolly, M Cmero, D Rosebrock, S Schumacher, Y Fan, M Fittall, R Drews, X Yao, J Lee, M Schlesner, H Zhu, D Adams, G Getz, P Boutros, M Imielinski, R Beroukhim, C Sahinalp, Y Ji, M Peifer, I Martincorena, F Markowetz, V Mustonen, K Yuan, M Gerstung, P Spellman, W Wang, Q Morris, D Wedge, P Van Loo, on behalf of the PCAWG Evolution and Heterogeneity Working Groupthe PCAWG consortium, the PCAWG consortium
Publication date:
1st Aug 2018
Full text
DOI